» Articles » PMID: 38884058

Bronchoalveolar Lavage Fluid Microbiota is Associated with the Diagnosis and Prognosis Evaluation of Lung Cancer

Overview
Journal Phenomics
Publisher Springer
Date 2024 Jun 17
PMID 38884058
Authors
Affiliations
Soon will be listed here.
Abstract

Supplementary Information: The online version contains supplementary material available at 10.1007/s43657-023-00135-9.

References
1.
Howlader N, Forjaz G, Mooradian M, Meza R, Kong C, Cronin K . The Effect of Advances in Lung-Cancer Treatment on Population Mortality. N Engl J Med. 2020; 383(7):640-649. PMC: 8577315. DOI: 10.1056/NEJMoa1916623. View

2.
Liu H, Tao L, Zhang J, Zhu Y, Zheng Y, Liu D . Difference of lower airway microbiome in bilateral protected specimen brush between lung cancer patients with unilateral lobar masses and control subjects. Int J Cancer. 2017; 142(4):769-778. DOI: 10.1002/ijc.31098. View

3.
Mao J, Wang D, Long J, Yang X, Lin J, Song Y . Gut microbiome is associated with the clinical response to anti-PD-1 based immunotherapy in hepatobiliary cancers. J Immunother Cancer. 2021; 9(12). PMC: 8650503. DOI: 10.1136/jitc-2021-003334. View

4.
Marshall E, Filho F, Sin D, Lam S, Leung J, Lam W . Distinct bronchial microbiome precedes clinical diagnosis of lung cancer. Mol Cancer. 2022; 21(1):68. PMC: 8900294. DOI: 10.1186/s12943-022-01544-6. View

5.
Roberti M, Yonekura S, Duong C, Picard M, Ferrere G, Alou M . Chemotherapy-induced ileal crypt apoptosis and the ileal microbiome shape immunosurveillance and prognosis of proximal colon cancer. Nat Med. 2020; 26(6):919-931. DOI: 10.1038/s41591-020-0882-8. View